<DOC>
	<DOCNO>NCT02243618</DOCNO>
	<brief_summary>Endoscopic submucosal dissection ( ESD ) advance technique enables en bloc resection superficial tumor gastrointestinal tract . ESD , however , time-consuming procedure require high level endoscopic skill achieve desirable oncologic outcome . Several procedure-related complication may occur ESD . Especially , iatrogenic ulcer bleed ESD concern endoscopists patient . In order reduce bleed rate , proton pump inhibitor ( PPIs ) administer ESD . In addition , ulcer protective agent rebamipide add PPIs accelerate ulcer healing . We aim evaluate efficacy polaprezinc heal iatrogenic ulcer .</brief_summary>
	<brief_title>The Effect Proton Pump Inhibitor Polaprezinc Combination Therapy Healing Endoscopic Submucosal Dissection-induced Ulcer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Rebamipide</mesh_term>
	<mesh_term>Polaprezinc</mesh_term>
	<criteria>1 . Age , 19 79 2 . Patients gastric adenoma early gastric cancer 3 . Patients ECOGPS 0 1 4 . Patients adequate renal function 5 . Patients adequate hepatic function 6 . Patients adequate bone marrow function 1 . Patients take medication ulcer include PPIs , H2 blocker , mucosal protective agent within 3 month prior ESD . 2 . Patients take steroid NSAIDswithin 3 month prior ESD . 3 . Patients undergone gastrostomy 4 . Patients allergy pantoprazole , polaprezinc , rebamipide . 5 . Pregnant breast feeding .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>